Condition: Hypochondroplasia · Sponsor: QED Therapeutics, a BridgeBio company
This is a long-term, multicenter, non-interventional study of children ages 2.5 to \<17 years with hypochondroplasia (HCH).
This description comes directly from the study's public registry record.
QED Therapeutics, Inc · 1-877-280-5655 · medinfo@qedtx.com
Always discuss trial participation with your own doctor first.
| UCSF Benioff Children's Hospital | Oakland, California, United States | Recruiting |
| Childrens Hospital Colorado | Aurora, Colorado, United States | Recruiting |
| Children's National Hospital | Washington D.C., District of Columbia, United States | Recruiting |
| Johns Hopkins School of Medicine | Baltimore, Maryland, United States | Recruiting |
| University of Missouri | Columbia, Missouri, United States | Recruiting |
| Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States | Recruiting |
| Vanderbilt University Medical Center | Nashville, Tennessee, United States | Recruiting |
| University of Wisconsin Madison - Waisman Center Bone Dysplasia Clinic | Madison, Wisconsin, United States | Recruiting |
| Murdoch Children's Research Institute - The Royal Children's Hospital Melbourne | Parkville, Victoria, Australia | Recruiting |
| London Health Sciences Centre - Children's Hospital of Western Ontario | London, Ontario, Canada | Recruiting |
| Children's Hospital of Eastern Ontario Research Institute | Ottawa, Ontario, Canada | Recruiting |
| Université de Montréal - Centre Hospitalier Universitaire Sainte-Justine | Montreal, Quebec, Canada | Recruiting |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06410976